Zentalis Pharmaceuticals Ratios (2022-2025) | ZNTL

Ratios Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Profitability
EBT Margin 25.11%-177.47%
EBIT Margin -61.06%-185.55%
EBITDA Margin -61.06%-185.55%
Operating Margin -61.06%-185.55%
Net Margin 24.75%-176.71%
FCF Margin -128.24%-147.78%
Efficiency
Assets Average 486.77M548.52M534.25M514.33M555.39M603.58M568.70M554.58M524.58M471.17M440.50M407.18M367.86M339.48M
Equity Average 394.24M450.78M431.38M409.84M454.47M502.59M459.64M448.08M420.68M368.46M345.76M316.28M284.94M263.68M
Invested Capital 315.67M472.82M428.74M434.02M385.67M523.28M481.90M437.39M458.77M382.58M354.33M337.19M295.38M274.50M252.87M
Leverage & Solvency
Equity Ratio 0.780.830.810.800.790.840.820.790.820.780.790.780.770.780.77
Valuation
Enterprise Value 1,129.70M1,255.49M1,191.95M1,106.53M985.90M1,411.45M1,305.80M561.01M1,080.72M253.47M220.36M-225.52M-234.68M-187.09M-169.37M
Market Capitalization 1,160.15M1,310.30M1,234.27M1,149.38M1,022.00M1,677.87M1,416.42M1,043.82M1,118.33M290.44M261.68M126.39M85.62M99.55M108.92M
Return Ratios
Return on Capital Employed -0.48%-0.51%-0.55%-0.52%-0.60%-0.52%-0.48%-0.50%-0.49%-0.59%-0.56%-0.55%
Return on Invested Capital -0.53%-0.57%-0.60%-0.56%-0.65%-0.58%
Return on Assets -0.41%-0.44%-0.47%-0.44%-0.49%-0.37%-0.37%-0.38%-0.38%-0.55%-0.44%-0.44%
Return on Equity -0.51%-0.55%-0.57%-0.52%-0.60%-0.46%-0.46%-0.49%-0.48%-0.71%-0.57%-0.57%